{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:33:15Z","timestamp":1792171995537,"version":"4.4.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.112094","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:58:53Z","timestamp":1629935933000},"page":"112094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus"],"prefix":"10.1016","volume":"142","author":[{"given":"Liyun","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112094_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2019.110609","article-title":"Effect of ultra-processed diet on gut microbiota and thus its role in neurodegenerative diseases","volume":"71","author":"Mart\u00ednez Leo","year":"2020","journal-title":"Nutrition"},{"issue":"5 Suppl","key":"10.1016\/j.biopha.2021.112094_bib2","first-page":"14s","article-title":"Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury","volume":"35","author":"Frazier","year":"2011","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"issue":"24","key":"10.1016\/j.biopha.2021.112094_bib3","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112094_bib4","first-page":"26050","article-title":"The composition of the gut microbiota throughout life, with an emphasis on early life","volume":"26","author":"Rodr\u00edguez","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"issue":"3","key":"10.1016\/j.biopha.2021.112094_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.numecd.2012.09.002","article-title":"The role of gut microbiota in human obesity: recent findings and future perspectives","volume":"23","author":"Tagliabue","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tem.2018.11.001","article-title":"Sex, microbes, and polycystic ovary syndrome","volume":"30","author":"Thackray","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1854642","article-title":"Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat","volume":"13","author":"Xia","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2021.112094_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104704","article-title":"Implications of gut microbiota dysbiosis and metabolic changes in prion disease","volume":"135","author":"Yang","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib9","doi-asserted-by":"crossref","first-page":"e2134","DOI":"10.1210\/clinem\/dgz263","article-title":"Obese adolescents with PCOS have altered biodiversity and relative abundance in gastrointestinal microbiota","volume":"105","author":"Jobira","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7122","key":"10.1016\/j.biopha.2021.112094_bib10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2021.112094_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009085","article-title":"Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults","volume":"5","author":"Larsen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.112094_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/07315724.2019.1657515","article-title":"A new approach to polycystic ovary syndrome: the gut microbiota","volume":"39","author":"Yurtdas","year":"2019","journal-title":"J. Am. Coll. Nutr."},{"issue":"5","key":"10.1016\/j.biopha.2021.112094_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","article-title":"Dysbiosis of Gut Microbiota (DOGMA)--a novel theory for the development of Polycystic Ovarian Syndrome","volume":"79","author":"Tremellen","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2021.112094_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112094_bib16","unstructured":"IDF, IDF Diabetes Atlas, ninth ed., Brussels, Belgium, 2019. Available at: https:\/\/www.diabetesatlas.org; 2019."},{"key":"10.1016\/j.biopha.2021.112094_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/nu12123719","article-title":"Role of gut microbiota on onset and progression of microvascular complications of type 2 diabetes (T2DM)","volume":"12","author":"Tanase","year":"2020","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.biopha.2021.112094_bib18","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1210\/jcem.87.5.8513","article-title":"Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity","volume":"87","author":"Legro","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.biopha.2021.112094_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115209","article-title":"Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients","volume":"9","author":"Balde\u00f3n R","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.112094_bib20","article-title":"Diabetes: a metabolic and reproductive disorder in women","author":"Thong","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1074248416686187","article-title":"Metabolic syndrome","volume":"22","author":"Sherling","year":"2017","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/cen.14101","article-title":"Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome","volume":"91","author":"Eyupoglu","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.biopha.2021.112094_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9132052","article-title":"The effectiveness of myo-inositol and D-chiro inositol treatment in type 2 diabetes","volume":"2016","author":"Pintaudi","year":"2016","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.biopha.2021.112094_bib24","first-page":"558","article-title":"N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications","volume":"18","author":"Salek","year":"2019","journal-title":"Excli J."},{"key":"10.1016\/j.biopha.2021.112094_bib25","article-title":"Vitamin D and polycystic ovary syndrome: a narrative review","author":"Mu","year":"2020","journal-title":"Reprod. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2021.112094_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1024\/1661-8157\/a003246","article-title":"[Ketogenic diet and its evidence-based therapeutic implementation in endocrine diseases]","volume":"108","author":"Stocker","year":"2019","journal-title":"Praxis"},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09513590.2016.1236078","article-title":"Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)","volume":"33","author":"Fruzzetti","year":"2017","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00404-017-4480-z","article-title":"Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis","volume":"296","author":"Xu","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/ijcp.12787","article-title":"Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis","volume":"70","author":"Graff","year":"2016","journal-title":"Int. J. Clin. Pract."},{"issue":"11","key":"10.1016\/j.biopha.2021.112094_bib30","article-title":"New therapeutic approaches in obesity and metabolic syndrome associated with polycystic ovary syndrome","volume":"9","author":"Saleem","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2021.112094_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.111965","article-title":"Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K\/Akt signaling pathway","volume":"250","author":"Qiu","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112094_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/a-1081-2036","article-title":"Exploration of the relationship between gut microbiota and polycystic ovary syndrome (PCOS): a review","volume":"80","author":"Zhao","year":"2020","journal-title":"Geburtshilfe Frauenheilkd."},{"issue":"23\u201324","key":"10.1016\/j.biopha.2021.112094_bib33","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1007\/s00253-019-10156-y","article-title":"Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus","volume":"103","author":"Salga\u00e7o","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112094_bib35","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.1039\/D0FO00302F","article-title":"The potential roles of chitosan oligosaccharide in prevention of kidney injury in obese and diabetic conditions","volume":"11","author":"Sutthasupha","year":"2020","journal-title":"Food Funct."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2021.112094_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","article-title":"Inflammatory mechanisms in the regulation of insulin resistance","volume":"14","author":"Tilg","year":"2008","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib37","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr. Rev."},{"issue":"Suppl 2","key":"10.1016\/j.biopha.2021.112094_bib38","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1055\/s-2001-18576","article-title":"Insulin resistance: definition and consequences","volume":"109","author":"Lebovitz","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"12","key":"10.1016\/j.biopha.2021.112094_bib39","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1464-5491.2011.03460.x","article-title":"Current perspectives of insulin resistance and polycystic ovary syndrome","volume":"28","author":"Pauli","year":"2011","journal-title":"Diabet. Med."},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib40","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr. Rev."},{"issue":"36","key":"10.1016\/j.biopha.2021.112094_bib41","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.2174\/1381612822666160720155855","article-title":"Insulin resistance and polycystic ovary syndrome","volume":"22","author":"Moghetti","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib42","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0015-0282(99)00118-1","article-title":"Alternate pathway 17,20-lyase enzyme activity in the adrenals is enhanced in patients with polycystic ovary syndrome","volume":"71","author":"Kele\u015ftimur","year":"1999","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.biopha.2021.112094_bib43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1677\/joe.1.07070","article-title":"Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women","volume":"192","author":"Corbould","year":"2007","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112094_bib44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00125-003-1097-5","article-title":"IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress","volume":"46","author":"Potashnik","year":"2003","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/dmrr.568","article-title":"Inflammation and the etiology of type 2 diabetes","volume":"22","author":"Sj\u00f6holm","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2021.112094_bib46","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.2337\/diabetes.53.suppl_3.S34","article-title":"Prevention of type 2 diabetes: insulin resistance and beta-cell function","volume":"53","author":"Chiasson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2021.112094_bib47","first-page":"8","article-title":"Insulin resistance and its impact on the approach to therapy of type 2 diabetes","volume":"121","author":"Laakso","year":"2001","journal-title":"Int. J. Clin. Pract. Suppl."},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib48","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.fertnstert.2011.02.041","article-title":"Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome","volume":"95","author":"Lecke","year":"2011","journal-title":"Fertil. Steril."},{"issue":"7121","key":"10.1016\/j.biopha.2021.112094_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2021.112094_bib50","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/REP-18-0583","article-title":"Obesity induces ovarian inflammation and reduces oocyte quality","volume":"158","author":"Snider","year":"2019","journal-title":"Reproduction"},{"issue":"3\u20134","key":"10.1016\/j.biopha.2021.112094_bib51","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00424-017-1955-5","article-title":"Macrophage function in obesity-induced inflammation and insulin resistance","volume":"469","author":"Lauterbach","year":"2017","journal-title":"Pflug. Arch."},{"issue":"0","key":"10.1016\/j.biopha.2021.112094_bib52","first-page":"1245","article-title":"Insulin resistance and chronic inflammation","volume":"70","author":"Matulewicz","year":"2016","journal-title":"Postep. Hig. Med. Doswiadczalnej"},{"issue":"Suppl 2","key":"10.1016\/j.biopha.2021.112094_bib53","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32 Suppl 2","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.biopha.2021.112094_bib54","doi-asserted-by":"crossref","first-page":"1917s","DOI":"10.1093\/jn\/127.9.1917S","article-title":"Potential role of TNFalpha and lipoprotein lipase as candidate genes for obesity","volume":"127","author":"Kern","year":"1997","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib55","first-page":"37","article-title":"Obesity and polycystic ovary syndrome","volume":"40","author":"Naderpoor","year":"2015","journal-title":"Minerva Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib56","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.biopha.2021.112094_bib57","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2021.112094_bib58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib59","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0889-8529(03)00071-9","article-title":"Obesity and type 2 diabetes","volume":"32","author":"Maggio","year":"2003","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"Suppl 2","key":"10.1016\/j.biopha.2021.112094_bib60","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ijo.0803730","article-title":"Role of obesity and adiposity in polycystic ovary syndrome","volume":"31","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Int. J. Obes."},{"issue":"12","key":"10.1016\/j.biopha.2021.112094_bib61","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/09513590.2012.683082","article-title":"Mediators of chronic inflammation in polycystic ovarian syndrome","volume":"28","author":"Deligeoroglou","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.biopha.2021.112094_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","article-title":"Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy","volume":"182","author":"Patel","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1023\/B:REMD.0000016125.05878.96","article-title":"Genetics of ovarian disorders: polycystic ovary syndrome","volume":"5","author":"Franks","year":"2004","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib64","first-page":"352","article-title":"The effect of curcumin on TNF-\u03b1, IL-6 and CRP expression in a model of polycystic ovary syndrome as an inflammation state","volume":"18","author":"Mohammadi","year":"2017","journal-title":"J. Reprod. Infertil."},{"issue":"5","key":"10.1016\/j.biopha.2021.112094_bib65","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1530\/REP-14-0435","article-title":"Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome","volume":"149","author":"Spritzer","year":"2015","journal-title":"Reproduction"},{"issue":"2","key":"10.1016\/j.biopha.2021.112094_bib66","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jcp.29912","article-title":"Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome","volume":"236","author":"Rostamtabar","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112094_bib67","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","article-title":"The multifaceted contributions of mitochondria to cellular metabolism","volume":"20","author":"Spinelli","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2021.112094_bib68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fendo.2019.00187","article-title":"Sirtuins and type 2 diabetes: role in inflammation, oxidative stress, and mitochondrial function","volume":"10","author":"Kitada","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2021.112094_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mito.2017.12.001","article-title":"Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases","volume":"41","author":"Dela Cruz","year":"2018","journal-title":"Mitochondrion"},{"issue":"8","key":"10.1016\/j.biopha.2021.112094_bib70","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1089\/dna.2019.5172","article-title":"Mitochondrial dysfunction in polycystic ovary syndrome","volume":"39","author":"Zeng","year":"2020","journal-title":"DNA Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-019-0509-4","article-title":"Polycystic ovary syndrome and mitochondrial dysfunction","volume":"17","author":"Zhang","year":"2019","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.biopha.2021.112094_bib72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/JIR.S232009","article-title":"Mitochondrial dynamic dysfunction as a main triggering factor for inflammation associated chronic non-communicable diseases","volume":"13","author":"Geto","year":"2020","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib73","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","article-title":"Role of mitochondrial dysfunction in insulin resistance","volume":"102","author":"Kim","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10741-015-9515-6","article-title":"Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes","volume":"21","author":"Patel","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.biopha.2021.112094_bib75","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.redox.2017.01.013","article-title":"Mitochondrial dynamics in type 2 diabetes: pathophysiological implications","volume":"11","author":"Rovira-Llopis","year":"2017","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112094_bib76","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/diacare.26.5.1589","article-title":"New insights on oxidative stress and diabetic complications may lead to a \u201ccausal\u201d antioxidant therapy","volume":"26","author":"Ceriello","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2021.112094_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/703538","article-title":"Mitochondrial dysfunction and \u03b2-cell failure in type 2 diabetes mellitus","volume":"2012","author":"Ma","year":"2012","journal-title":"Exp. Diabetes Res."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2021.112094_bib78","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","article-title":"Mitochondrial formation of reactive oxygen species","volume":"552","author":"Turrens","year":"2003","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112094_bib79","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.embor.7400731","article-title":"The gut flora as a forgotten organ","volume":"7","author":"O\u2019Hara","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2021.112094_bib80","article-title":"Metabolic networks of the human gut microbiota","author":"Selber-Hnatiw","year":"2019","journal-title":"Microbiology"},{"issue":"7351","key":"10.1016\/j.biopha.2021.112094_bib81","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10213","article-title":"Human nutrition, the gut microbiome and the immune system","volume":"474","author":"Kau","year":"2011","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biopha.2021.112094_bib82","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1365-2222.2009.03326.x","article-title":"Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses","volume":"39","author":"Sj\u00f6gren","year":"2009","journal-title":"Clin. Exp. Allergy"},{"issue":"3","key":"10.1016\/j.biopha.2021.112094_bib83","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2016.02.006","article-title":"Gut microbiota-induced immunoglobulin G controls systemic infection by symbiotic bacteria and pathogens","volume":"44","author":"Zeng","year":"2016","journal-title":"Immunity"},{"issue":"36","key":"10.1016\/j.biopha.2021.112094_bib84","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.2174\/1381612822666160715143933","article-title":"Gut-brain axis and metabolism in polycystic ovary syndrome","volume":"22","author":"Saydam","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.biopha.2021.112094_bib85","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","article-title":"Gender bias in autoimmunity is influenced by microbiota","volume":"39","author":"Yurkovetskiy","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2021.112094_bib86","article-title":"Gut microbiota in patients with polycystic ovary syndrome: a systematic review","author":"Guo","year":"2021","journal-title":"Reprod. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib87","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2017-02153","article-title":"Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2021.112094_bib88","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/mSystems.00017-19","article-title":"Probiotic Bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis","volume":"4","author":"Zhang","year":"2019","journal-title":"mSystems"},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153196","article-title":"Association between polycystic ovary syndrome and gut microbiota","volume":"11","author":"Guo","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biopha.2021.112094_bib90","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib91","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13048-018-0457-1","article-title":"The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome","volume":"11","author":"Jamilian","year":"2018","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib92","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.resmic.2018.09.002","article-title":"Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study","volume":"170","author":"Zeng","year":"2019","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.biopha.2021.112094_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108689","article-title":"Differential gut microbiota composition between type 2 diabetes mellitus patients and healthy controls: a systematic review","volume":"173","author":"Umirah","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"7418","key":"10.1016\/j.biopha.2021.112094_bib94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-15-0094","article-title":"Gut microbiota and diet in patients with different glucose tolerance","volume":"5","author":"Egshatyan","year":"2016","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.biopha.2021.112094_bib96","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3389\/fimmu.2017.01107","article-title":"Detection of increased plasma interleukin-6 levels and prevalence of Prevotella copri and Bacteroides vulgatus in the feces of type 2 diabetes patients","volume":"8","author":"Leite","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2021.112094_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"issue":"22","key":"10.1016\/j.biopha.2021.112094_bib98","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2021.112094_bib99","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/biomedicines8010008","article-title":"The gut microbiome and type 2 diabetes mellitus: discussing a complex relationship","volume":"8","author":"Sikalidis","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2021.112094_bib100","doi-asserted-by":"crossref","DOI":"10.1111\/and.13617","article-title":"Obesity and male infertility: mechanisms and management","volume":"53","author":"Leisegang","year":"2021","journal-title":"Andrologia"},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib101","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.fertnstert.2014.06.027","article-title":"Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome","volume":"102","author":"Chen","year":"2014","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.biopha.2021.112094_bib102","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/19490976.2019.1592421","article-title":"Gut bacteria signaling to mitochondria in intestinal inflammation and cancer","volume":"11","author":"Jackson","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2021.112094_bib103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12937-016-0166-9","article-title":"Pathophysiological role of host microbiota in the development of obesity","volume":"15","author":"Kobyliak","year":"2016","journal-title":"Nutr. J."},{"issue":"3","key":"10.1016\/j.biopha.2021.112094_bib104","doi-asserted-by":"crossref","first-page":"G542","DOI":"10.1152\/ajpgi.00286.2019","article-title":"Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD","volume":"318","author":"Zeng","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112094_bib105","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2249.2001.01370.x","article-title":"Neutrophil accumulation induced by bacterial lipopolysaccharide: effects of dexamethasone and annexin 1","volume":"123","author":"Allcock","year":"2001","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112094_bib107","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1113\/JP272476","article-title":"Potential mediators linking gut bacteria to metabolic health: a critical view","volume":"595","author":"Janssen","year":"2017","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112094_bib108","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvz039","article-title":"Intestinal barrier dysfunction, LPS translocation, and disease development","volume":"4","author":"Ghosh","year":"2020","journal-title":"J. Endocr. Soc."},{"issue":"11","key":"10.1016\/j.biopha.2021.112094_bib109","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1007\/s00125-007-0791-0","article-title":"Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia","volume":"50","author":"Cani","year":"2007","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.biopha.2021.112094_bib110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1099\/mic.0.000853","article-title":"Metabolic networks of the human gut microbiota","volume":"166","author":"Selber-Hnatiw","year":"2020","journal-title":"Microbiology"},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib111","first-page":"1","article-title":"Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs)","volume":"66","author":"Ratajczak","year":"2019","journal-title":"Acta Biochim. Pol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112094_bib112","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrmicro3344","article-title":"The gut microbiota, bacterial metabolites and colorectal cancer","volume":"12","author":"Louis","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2021.112094_bib113","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3390\/nu12041107","article-title":"The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome","volume":"12","author":"Markowiak-Kope\u0107","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2021.112094_bib114","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/nu12041185","article-title":"Intestinal permeability, inflammation and the role of nutrients","volume":"12","author":"Farr\u00e9","year":"2020","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.biopha.2021.112094_bib115","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.biopha.2021.112094_bib116","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: an evolving relationship","volume":"63","author":"Tilg","year":"2014","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.biopha.2021.112094_bib117","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.dsx.2018.04.015","article-title":"Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial","volume":"12","author":"Kobyliak","year":"2018","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.biopha.2021.112094_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109138","article-title":"Research progress in the relationship between type 2 diabetes mellitus and intestinal flora","volume":"117","author":"Ma","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib119","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1152\/physiol.00041.2015","article-title":"Linking gut microbiota and inflammation to obesity and insulin resistance","volume":"31","author":"Saad","year":"2016","journal-title":"Physiology"},{"key":"10.1016\/j.biopha.2021.112094_bib120","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3389\/fmicb.2015.01151","article-title":"Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes","volume":"6","author":"Palau-Rodriguez","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2021.112094_bib121","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6138438","article-title":"Bile acids: key regulators and novel treatment targets for type 2 diabetes","volume":"2020","author":"Wu","year":"2020","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib122","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2017.11.002","article-title":"Role of bile acids in metabolic control","volume":"29","author":"Molinaro","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2021.112094_bib123","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jsbmb.2019.03.005","article-title":"Increased circulating conjugated primary bile acids are associated with hyperandrogenism in women with polycystic ovary syndrome","volume":"189","author":"Zhang","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112094_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106993","article-title":"Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats","volume":"9","author":"Mahmoud","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib125","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/09513590.2015.1134478","article-title":"Histopathologic and metabolic effect of ursodeoxycholic acid treatment on PCOS rat model","volume":"32","author":"Gozukara","year":"2016","journal-title":"Gynecol. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112094_bib126","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3945\/jn.116.240481","article-title":"Microbiota-gut-brain axis: modulator of host metabolism and appetite","volume":"147","author":"van de Wouw","year":"2017","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib127","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.biopha.2021.112094_bib128","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/jcb.27635","article-title":"Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics","volume":"120","author":"Chen","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2021.112094_bib129","article-title":"Ge-Gen-Jiao-Tai-Wan affects type 2 diabetic rats by regulating gut microbiota and primary bile acids","volume":"2021","author":"Chen","year":"2021","journal-title":"Evid. Based Complement. Altern. Med. eCAM"},{"key":"10.1016\/j.biopha.2021.112094_bib130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijms19040954","article-title":"Branched chain amino acids: beyond nutrition metabolism","volume":"19","author":"Nie","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib131","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nchembio.1961","article-title":"Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis","volume":"12","author":"Green","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112094_bib132","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11892-018-1048-7","article-title":"Branched chain amino acids in metabolic disease","volume":"18","author":"Arany","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.biopha.2021.112094_bib133","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/nu8070405","article-title":"The emerging role of branched-chain amino acids in insulin resistance and metabolism","volume":"8","author":"Yoon","year":"2016","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.biopha.2021.112094_bib134","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/1753-0407.12645","article-title":"Diabetes and branched-chain amino acids: what is the link?","volume":"10","author":"Bloomgarden","year":"2018","journal-title":"J. Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2021.112094_bib135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib136","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/asj.12937","article-title":"Regulation of intestinal health by branched-chain amino acids","volume":"89","author":"Zhou","year":"2018","journal-title":"Anim. Sci. J."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib137","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1541-4337.12401","article-title":"Dietary amino acids and the gut-microbiome-immune axis: physiological metabolism and therapeutic prospects","volume":"18","author":"Ma","year":"2019","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"issue":"10","key":"10.1016\/j.biopha.2021.112094_bib138","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/17512433.2019.1670058","article-title":"Gut microbiota: what is its place in pharmacology?","volume":"12","author":"Tarasiuk","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112094_bib139","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4014\/jmb.1906.06064","article-title":"Role of probiotics in human gut microbiome-associated diseases","volume":"29","author":"Kim","year":"2019","journal-title":"J. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S095442241700018X","article-title":"Probiotics, prebiotics, synbiotics and insulin sensitivity","volume":"31","author":"Kim","year":"2018","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.biopha.2021.112094_bib141","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.diabres.2016.06.014","article-title":"Probiotics for the management of type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"118","author":"Samah","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"10","key":"10.1016\/j.biopha.2021.112094_bib142","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1017\/S0007114519000461","article-title":"Dietary \u03b1-lactalbumin alters energy balance, gut microbiota composition and intestinal nutrient transporter expression in high-fat diet-fed mice","volume":"121","author":"Boscaini","year":"2019","journal-title":"Br. J. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3213","article-title":"Probiotics for the treatment of type 2 diabetes: a review of randomized controlled trials","volume":"36","author":"Tiderencel","year":"2020","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib144","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1039\/C9FO02554E","article-title":"Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota","volume":"11","author":"He","year":"2020","journal-title":"Food Funct."},{"issue":"10","key":"10.1016\/j.biopha.2021.112094_bib145","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1507\/endocrj.EJ18-0567","article-title":"Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice","volume":"66","author":"Xue","year":"2019","journal-title":"Endocr. J."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib146","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13048-018-0411-2","article-title":"Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women","volume":"11","author":"Montanino Oliva","year":"2018","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib147","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3748\/wjg.v24.i1.5","article-title":"Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation","volume":"24","author":"Shen","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112094_bib148","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF03401517","article-title":"Gut microbiota and obesity: implications for fecal microbiota transplantation therapy","volume":"16","author":"Kang","year":"2017","journal-title":"Hormones"},{"key":"10.1016\/j.biopha.2021.112094_bib149","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3389\/fimmu.2019.02653","article-title":"Fecal microbiota transplantation: a potential tool for treatment of human female reproductive tract diseases","volume":"10","author":"Quaranta","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2021.112094_bib150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fcimb.2019.00455","article-title":"Promising treatment for type 2 diabetes: fecal microbiota transplantation reverses insulin resistance and impaired islets","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112094_bib151","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41401-019-0330-9","article-title":"Fecal microbiota transplantation improves metabolism and gut microbiome composition in db\/db mice","volume":"41","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2021.112094_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.590370","article-title":"Microbiota transplant in the treatment of obesity and diabetes: current and future perspectives","volume":"11","author":"Napolitano","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2021.112094_bib153","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3940739","article-title":"Interplay between the adaptive immune system and insulin resistance in weight loss induced by bariatric surgery","volume":"2019","author":"Villarreal-Calder\u00f3n","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.biopha.2021.112094_bib154","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13679-019-00351-3","article-title":"Gut microbiota dysbiosis in human obesity: impact of bariatric surgery","volume":"8","author":"Deb\u00e9dat","year":"2019","journal-title":"Curr. Obes. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdi.12687","article-title":"Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes","volume":"9","author":"Liu","year":"2018","journal-title":"J. Diabetes Investig."},{"issue":"9","key":"10.1016\/j.biopha.2021.112094_bib156","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/oby.2009.102","article-title":"Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism","volume":"17","author":"Patti","year":"2009","journal-title":"Obesity"},{"issue":"7","key":"10.1016\/j.biopha.2021.112094_bib157","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.4358","article-title":"Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention","volume":"23","author":"Liu","year":"2017","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib158","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11695-016-2399-2","article-title":"Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission","volume":"27","author":"Murphy","year":"2017","journal-title":"Obes. Surg."},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib159","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","article-title":"The impact of dietary fiber on gut microbiota in host health and disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.biopha.2021.112094_bib160","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cmet.2015.07.026","article-title":"Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling","volume":"22","author":"Caesar","year":"2015","journal-title":"Cell Metab."},{"issue":"6052","key":"10.1016\/j.biopha.2021.112094_bib161","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib162","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12967-017-1175-y","article-title":"Influence of diet on the gut microbiome and implications for human health","volume":"15","author":"Singh","year":"2017","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.112094_bib163","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s42000-019-00093-w","article-title":"Metformin and gut microbiota: their interactions and their impact on diabetes","volume":"18","author":"Vallianou","year":"2019","journal-title":"Hormones"},{"key":"10.1016\/j.biopha.2021.112094_bib164","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jsbmb.2016.09.017","article-title":"Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome","volume":"175","author":"Wimalawansa","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112094_bib165","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jnutbio.2015.01.002","article-title":"Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats","volume":"26","author":"Etxeberria","year":"2015","journal-title":"J. Nutr. Biochem."},{"issue":"7","key":"10.1016\/j.biopha.2021.112094_bib166","first-page":"538","article-title":"[Possibility of acupuncture treatment of ischemic stroke via regulating intestinal flora-immune response]","volume":"44","author":"Ma","year":"2019","journal-title":"Zhen Ci Yan Jiu"},{"key":"10.1016\/j.biopha.2021.112094_bib167","first-page":"1","article-title":"Regulating gut flora dysbiosis in obese mice by electroacupuncture","author":"Si","year":"2018","journal-title":"Am. J. Chin. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.112094_bib168","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/j.2040-4603.2012.tb00425.x","article-title":"Lack of exercise is a major cause of chronic diseases","volume":"2","author":"Booth","year":"2012","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.biopha.2021.112094_bib169","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1900\/RDS.2019.15.35","article-title":"Impact of physical exercise on gut microbiome, inflammation, and the pathobiology of metabolic disorders","volume":"15","author":"Sohail","year":"2019","journal-title":"Rev. Diabet. Stud."},{"issue":"1","key":"10.1016\/j.biopha.2021.112094_bib170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12944-017-0653-9","article-title":"Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases","volume":"17","author":"Chen","year":"2018","journal-title":"Lipids Health Dis."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:43:58Z","timestamp":1760100238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221008775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":170,"alternative-id":["S0753332221008775"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112094","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112094"}}